Evidence map›Paper›PMID 33223758›Full record

ArticleChinese journal of cancer research = Chung-kuo yen cheng yen chiu2020

Impact of diabetes on prognosis of gastric cancer patients performed with gastrectomy.

Xinhua Chen, Yuehong Chen, Tao Li, Luo Jun, Tian Lin, Yanfeng Hu, Huilin Huang, Hao Chen, Hao Liu, Tuanjie Li and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Chinese journal of cancer research = Chung-kuo yen cheng yen chiu, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Type 2 diabetes in patients undergoing gastric cancer surgery: areas requiring disease-specific glycemic management.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2025
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Advances in Treatment Models of Advanced Gastric Cancer.Technology in cancer research & treatment
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Xinhua ChenDepartment of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Yuehong ChenDepartment of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Tao LiDepartment of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Luo JunDepartment of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Tian LinDepartment of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Yanfeng HuDepartment of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Huilin HuangDepartment of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Hao ChenDepartment of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Hao LiuDepartment of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Tuanjie LiDepartment of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Guoxin LiDepartment of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Jiang YuDepartment of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study aimed to determine the impact of type 2 diabetes mellitus (T2DM) on clinical outcomes of gastric cancer (GC) patients and explore whether metformin use and good glycemic control could reverse it.

methodsClinicopathologic data of consecutive GC patients who underwent gastrectomy at Nanfang Hospital between October 2004 and December 2015 were included. Propensity score matching (PSM) was performed to balance the important factors of the disease status between non-T2DM and T2DM group. The last follow-up time was January 2019.

resultsA total of 1,692 eligible patients (1,621 non-T2DM

conclusionsDM promoted disease progress of GC after gastrectomy but had not yet led to the significant discrepancy of CSS. For GC patients with T2DM, metformin use was associated with superior survival but without statistical significance, while better glycemic control could not improve the prognosis.

Indexed as

diabetes mellitusgastrectomyGastric cancerglycemicmetforminprognosis

Identifiers

PMID33223758
PMCPMC7666786

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.